
Quarterly report 2024-Q3
added 10-28-2024
Inari Medical Market Cap 2011-2026 | NARI
As of April 07, 2026 Inari Medical has a market cap of $ 4.23 B
Capitalization is the market value of a company whose shares are traded on the stock exchange. It is calculated by multiplying the market price of a share by the total number of the company's shares. Capitalization indicates volatility, risk, and growth potential. This metric is often used for a quick assessment of a company’s investment profile.[1]
Capitalization is an important indicator for investors and analysts, as it helps determine the size and significance of a company in the stock market. Companies with large capitalization are considered more stable and reliable, as they have more resources and financial power to grow and survive in the market.
This metric can be divided into several categories: small (from 300 million to 2 billion dollars), medium (from 2 to 10 billion dollars), and large (over 10 billion dollars). Companies with different levels of capitalization have their own characteristics and risks, so investors usually take this indicator into account when making investment decisions.
Capitalization can also change over time depending on the share price and the number of shares in circulation. Therefore, it is a dynamic indicator that requires constant monitoring and analysis to make well-informed investment decisions.
Annual Market Cap Inari Medical
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 3.07 B | 3.66 B | 3.06 B | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 3.66 B | 3.06 B | 3.26 B |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.
Market Cap of other stocks in the Medical devices industry
| Issuer | Market Cap | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
GenMark Diagnostics, Inc.
GNMK
|
933 M | - | - | $ 1.77 B | ||
|
Acutus Medical
AFIB
|
5.24 M | - | -26.83 % | $ 2.62 M | ||
|
AdaptHealth Corp.
AHCO
|
1.2 B | $ 12.07 | 0.33 % | $ 1.63 B | ||
|
Allied Healthcare Products
AHPI
|
4.01 M | - | 3.58 % | $ 2.21 M | ||
|
Lianluo Smart Limited
LLIT
|
147 M | - | 24.59 % | $ 44.8 M | ||
|
EDAP TMS S.A.
EDAP
|
139 M | $ 3.45 | 1.77 % | $ 129 M | ||
|
Obalon Therapeutics, Inc.
OBLN
|
35 M | - | -5.86 % | $ 30.6 M | ||
|
Apollo Endosurgery
APEN
|
403 M | - | - | $ 475 M | ||
|
CryoLife, Inc.
CRY
|
906 M | - | -4.14 % | $ 702 M | ||
|
Avinger
AVGR
|
2.59 M | - | -20.74 % | $ 369 K | ||
|
Align Technology
ALGN
|
13.9 B | $ 171.87 | 0.74 % | $ 12.9 B | ||
|
CHF Solutions, Inc.
CHFS
|
1.05 M | - | 1.15 % | $ 34.5 M | ||
|
AxoGen
AXGN
|
1.5 B | $ 32.64 | -5.23 % | $ 1.5 B | ||
|
Axonics Modulation Technologies
AXNX
|
2.82 B | - | - | $ 3.31 B | ||
|
Aziyo Biologics
AZYO
|
26.9 M | - | 1.37 % | $ 20.5 M | ||
|
Soliton, Inc.
SOLY
|
229 M | - | -1.42 % | $ 435 M | ||
|
Hancock Jaffe Laboratories, Inc.
HJLI
|
7.99 M | - | -1.98 % | $ 98.3 M | ||
|
Itamar Medical Ltd.
ITMR
|
339 M | - | 0.03 % | $ 1.58 B | ||
|
Misonix, Inc.
MSON
|
185 M | - | - | $ 462 M | ||
|
Neovasc
NVCN
|
677 M | - | - | $ 111 M | ||
|
Butterfly Network
BFLY
|
766 M | $ 4.13 | 0.49 % | $ 874 M | ||
|
Intersect ENT, Inc.
XENT
|
735 M | - | - | $ 955 M | ||
|
BIOLASE
BIOL
|
192 K | - | -13.19 % | $ 166 K | ||
|
Bruker Corporation
BRKR
|
6.9 K | $ 36.74 | -0.05 % | $ 5.47 K | ||
|
BioSig Technologies
BSGM
|
7.3 M | - | 37.08 % | $ 85.7 M | ||
|
Boston Scientific Corporation
BSX
|
113 B | $ 62.59 | -0.37 % | $ 92.7 B | ||
|
Alphatec Holdings
ATEC
|
2.07 B | $ 10.97 | 1.29 % | $ 1.65 B | ||
|
CONMED Corporation
CNMD
|
1.32 B | - | - | $ 1.06 B | ||
|
Conformis
CFMS
|
12.6 M | - | - | $ 16.4 M | ||
|
ClearPoint Neuro
CLPT
|
316 M | $ 9.38 | 0.11 % | $ 266 M | ||
|
Cardiovascular Systems
CSII
|
588 M | - | 0.15 % | $ 844 M | ||
|
Cytosorbents Corporation
CTSO
|
34.8 M | $ 0.59 | 1.2 % | $ 36.7 M | ||
|
Cutera
CUTR
|
46.5 M | - | -10.19 % | $ 1.99 M | ||
|
Delcath Systems
DCTH
|
326 M | $ 9.7 | 0.73 % | $ 347 M | ||
|
Dynatronics Corporation
DYNT
|
1.95 M | - | 14.99 % | $ 929 K | ||
|
Eargo
EAR
|
17 M | - | - | $ 10.2 M | ||
|
Edwards Lifesciences Corporation
EW
|
48.8 B | $ 81.19 | 0.17 % | $ 47.5 B | ||
|
Second Sight Medical Products
EYES
|
225 M | - | -0.97 % | $ 54.4 M | ||
|
Electromed
ELMD
|
175 M | $ 23.61 | 1.37 % | $ 200 M | ||
|
FONAR Corporation
FONR
|
85.2 M | $ 18.6 | 0.05 % | $ 122 M | ||
|
Globus Medical
GMED
|
12.5 B | $ 88.6 | 0.77 % | $ 12 B | ||
|
Helius Medical Technologies
HSDT
|
3.54 M | $ 1.9 | 2.15 % | $ 1.15 M | ||
|
Integra LifeSciences Holdings Corporation
IART
|
1.88 B | $ 9.31 | -2.31 % | $ 717 M | ||
|
Inogen
INGN
|
160 M | $ 6.36 | 2.42 % | $ 169 M | ||
|
Inspire Medical Systems
INSP
|
1.76 B | $ 54.14 | -1.55 % | $ 1.59 B | ||
|
IRIDEX Corporation
IRIX
|
16.6 M | $ 1.0 | 1.66 % | $ 16.9 M | ||
|
IRadimed Corporation
IRMD
|
1.25 B | $ 95.66 | -0.59 % | $ 1.22 B | ||
|
Integer Holdings Corporation
ITGR
|
2.98 B | $ 85.63 | -1.4 % | $ 2.97 B | ||
|
Invacare Corporation
IVC
|
24.1 M | - | - | $ 24.7 M | ||
|
GBS
GBS
|
2.48 M | - | -0.57 % | $ 7.12 M |